Retinitis Pigmentosa Market Forecast 2024-2033

 Overview and Scope

The retinitis pigmentosa market consists of revenues earned by entities by providing services such as genetic counseling, low vision therapy, psychological support, and educational support. The market value includes the value of related goods sold by the service provider or included within the service offering. The retinitis pigmentosa market also includes sales of retinal implants, screen readers, telescopic glasses, and adaptive lighting. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Sizing and Forecast
The retinitis pigmentosa market size has grown strongly in recent years. It will grow from $10.52 billion in 2023 to $11.32 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to genetic research advancements, the development of retinal imaging technologies, increased awareness campaigns, growing patient advocacy groups, and the expansion of clinical trial networks.



The retinitis pigmentosa market size is expected to see strong growth in the next few years. It will grow to $15.23 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to advancements in stem cell research for retinal regeneration, personalized medicine approaches, increased investment in orphan drug development, and expansion of telemedicine services. Major trends in the forecast period include a shift towards combination therapies, a rise in patient-centric clinical trial designs, the adoption of value-based pricing models, and the integration of digital therapeutics.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/retinitis-pigmentosa-global-market-report 

Segmentation & Regional Insights
The retinitis pigmentosa market covered in this report is segmented –

1) By Type: Autosomal Recessive, Autosomal Dominant, X-Linked
2) By Treatment: Vitamin A, Docosahexaenoic Acid (DHA), Calcium Channel Blockers, Gene Therapy, Retinal Eye Prosthetics, Other Treatments
3) By Diagnosis: Electroretinogram, Visual Field Testing, Genetic Testing, Other Diagnosis
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-users: Hospitals, Specialty Clinics, Homecare, Other End-users

North America was the largest region in the retinitis pigmentosa market in 2023. The regions covered in the retinitis pigmentosa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16528&type=smp 

Major Driver Impacting Market Growth
The increase in healthcare expenditure is expected to propel the growth of the retinitis pigmentosa market going forward. Healthcare expenditure refers to the total amount of money spent on healthcare goods and services, including medical treatments, medications, hospitalizations, and preventive care, within a specified period, reflecting the overall cost of healthcare provision within a population. Healthcare expenditure is rising due to the increasing cost of advanced medical technologies, aging populations, and the prevalence of chronic diseases. Healthcare expenditure for retinitis pigmentosa is focused on advancing diagnostic methods, developing effective treatments, and providing supportive care to manage vision loss. For instance, in January 2024, according to the National Institutes of Health, a US-based government agency, healthcare expenditure in the US rose by 4.1% in 2022 to reach $4.5 trillion, representing a faster growth rate compared to the 3.2% increase observed in 2021. Therefore, the increase in healthcare expenditure is driving the growth of the retinitis pigmentosa market.

Key Industry Players
Major companies operating in the retinitis pigmentosa market are Johnson & Johnson, Novartis AG, AbbVie Inc., Astellas Pharma Inc., Biogen Inc., Sun Pharmaceutical Industries Ltd, Spark Therapeutics, REGENXBIO Inc., Editas Medicine, IVERIC bio, MeiraGTx Holdings, Gensight Biologics, Second Sight Medical Products, Copernicus Therapeutics Inc., Kiora Pharmaceuticals, 4D Molecular Therapeutics, ReNeuron Group, Acucela Inc., AGTC (Applied Genetic Technologies Corporation), Editgene

The retinitis pigmentosa market report table of contents includes:


1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis


Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info 

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
Twitter: https://twitter.com/tbrc_info 
Facebook: https://www.facebook.com/TheBusinessResearchCompany 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ 

Comments

Post a Comment

Popular posts from this blog

Chillers Market Outlook 2024-2033: Trends and Projections

Image
  Market Size - The chillers market size has grown steadily in recent years. It will grow from $9.04 billion in 2023 to $9.43 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to growth in industrial and commercial construction, expansion of hvacr systems in residential and commercial buildings, adoption of process cooling in industrial applications, increased in demand for air conditioning and refrigeration, focus on energy efficiency and sustainable cooling solutions. The chillers market size is expected to see strong growth in the next few years. It will grow to $11.68 billion in 2028 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to urbanization and growth of megacities driving demand for cooling solutions, expansion of data centers and it infrastructure, adoption of chillers in food and beverage processing, demand for district cooling systems in urban develo...
Read more

Integrated Pest Management IPM Market Outlook 2024-2033: Trends and Projections

Image
  Market Size - The integrated pest management (ipm) market size has grown strongly in recent years. It will grow from $124.96 billion in 2023 to $134.68 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to environmental concerns, regulatory pressures, consumer demand, cost savings. The integrated pest management (ipm) market size is expected to see strong growth in the next few years. It will grow to $184.94 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to climate change impact, global food security concerns, collaborative initiatives, . Major trends in the forecast period include technology advancements, market expansion, biological control methods, digital agriculture integration, crop-specific ipm solutions, biotechnology innovations, focus on non-chemical alternatives, certification programs. Order your report now for swift delivery @ https:...
Read more

Congenital Heart Defect Devices Market Outlook 2024-2033: Trends and Projections

Image
  Market Size -   The congenital heart defect devices market size has grown strongly in recent years. It will grow from $2.72 billion in 2023 to $2.91 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to growth in healthcare awareness campaigns, increasing number of heart defect screening programs, growth in medical device regulations, increasing prevalence of congenital heart defect, and increase in the risk of organ failure. The congenital heart defect devices market size is expected to see strong growth in the next few years. It will grow to $3.86 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing clinical trials, a surge in the geriatric population, an increasing prevalence of congenital heart defects, rising government support and funding, and an increasing number of specialized medical centers. Major trends in the forecast per...
Read more